Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

by George C. Leef, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Werner Hacke, Christopher C. Nessel, Daniel E. Singer, Keith A.A. Fox, Kenneth W. Mahaffey, Jonathan P. Piccini
Published 2017-11-01

Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial

by Anthony P. Carnicelli, Anne S. Hellkamp, Kenneth W. Mahaffey, Daniel E. Singer, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Robert M. Califf, Manesh R. Patel
Published 2021-10-01

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

by Gene R. Quinn, Anne S. Hellkamp, Graeme J. Hankey, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Maurizio Fava, Keith A. A. Fox, Jonathan L. Halperin, Kenneth W. Mahaffey, Christopher C. Nessel, Manesh R. Patel, Jonathan P. Piccini, Daniel E. Singer
Published 2018-08-01

Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF

by Leo Ungar, Fatima Rodriguez, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A. A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Manesh R. Patel, Jonathan P. Piccini, Kenneth W. Mahaffey
Published 2019-08-01

Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis

by Josephine Harrington, Anne S. Hellkamp, Kenneth W. Mahaffey, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Daniel E. Singer, Shaun G. Goodman, Manesh R. Patel, Jonathan P. Piccini
Published 2024-06-01

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

by Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Scott D. Berkowitz, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A. A. Fox, Robert M. Califf
Published 2016-03-01

Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF

by Francis E. Ugowe, MD, Anne S. Hellkamp, MS, Allen Wang, BS, Richard C. Becker, MD, Scott D. Berkowitz, MD, Günter Breithardt, MD, Keith A.A. Fox, MB ChB, Jonathan L. Halperin, MD, Graeme J. Hankey, MD, Kenneth W. Mahaffey, MD, Christopher C. Nessel, MD, Daniel E. Singer, MD, Manesh R. Patel, MD, Jonathan P. Piccini, MD, MHS, FHRS
Published 2021-06-01